FOLR2 and rheumatoid arthritis: Since FR-β has been recognized as an important transport route for methotrexate, the standard of care in RA therapy, it is not surprising that FR-β has been predominantly targeted for the evaluation of its diagnostic and therapeutic value in preclinical models of RA [51,52].